ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 161 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2015. The put-call ratio across all filers is 1.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $210,000 | -0.9% | 3,375 | +8.0% | 0.00% | 0.0% |
| Q1 2017 | $212,000 | -12.0% | 3,125 | -8.8% | 0.00% | 0.0% |
| Q4 2016 | $241,000 | -74.3% | 3,425 | -74.1% | 0.00% | -72.7% |
| Q3 2016 | $936,000 | -42.7% | 13,200 | -60.5% | 0.01% | +10.0% |
| Q2 2016 | $1,634,000 | +59.3% | 33,400 | +106.2% | 0.01% | -28.6% |
| Q1 2016 | $1,026,000 | -44.1% | 16,200 | -0.9% | 0.01% | -44.0% |
| Q4 2015 | $1,834,000 | +73.2% | 16,350 | +48.6% | 0.02% | +78.6% |
| Q3 2015 | $1,059,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |